Insider Selling: Tempus AI (NASDAQ:TEM) EVP Sells 6,387 Shares of Stock

Tempus AI, Inc. (NASDAQ:TEM) EVP Andrew Polovin sold 6,387 shares of the business’s stock in a transaction on Wednesday, November 19th. The stock was sold at an average price of $68.06, for a total value of $434,699.22. Following the sale, the executive vice president directly owned 120,464 shares in the company, valued at $8,198,779.84. This trade represents a 5.04% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website.

Andrew Polovin also recently made the following trade(s):

• On Tuesday, November 18th, Andrew Polovin sold 5,205 shares of Tempus AI stock. The shares were sold at an average price of $65.54, for a total value of $341,135.70.

Tempus AI Trading Down 4.9%

NASDAQ TEM traded down $3.40 on Thursday, hitting $65.69. 7,149,431 shares of the company were exchanged, compared to its average volume of 11,236,510. The company has a debt-to-equity ratio of 2.45, a current ratio of 3.28 and a quick ratio of 3.12. Tempus AI, Inc. has a twelve month low of $31.36 and a twelve month high of $104.32. The firm has a market capitalization of $11.69 billion, a P/E ratio of -55.20 and a beta of 4.86. The company’s 50 day moving average price is $84.42 and its 200-day moving average price is $71.91.

Tempus AI (NASDAQ:TEM) last released its earnings results on Tuesday, November 4th. The company reported ($0.11) earnings per share for the quarter, topping the consensus estimate of ($0.16) by $0.05. Tempus AI had a negative net margin of 18.45% and a negative return on equity of 73.21%. The business had revenue of $334.21 million for the quarter, compared to the consensus estimate of $328.89 million. During the same period last year, the firm posted ($0.46) earnings per share. The firm’s quarterly revenue was up 84.7% compared to the same quarter last year. Tempus AI has set its FY 2025 guidance at EPS. Analysts predict that Tempus AI, Inc. will post -6.15 earnings per share for the current fiscal year.

Institutional Investors Weigh In On Tempus AI

Several institutional investors have recently made changes to their positions in TEM. Vanguard Group Inc. lifted its stake in Tempus AI by 6,247.5% in the first quarter. Vanguard Group Inc. now owns 5,995,117 shares of the company’s stock valued at $289,204,000 after acquiring an additional 5,900,668 shares during the last quarter. ARK Investment Management LLC boosted its holdings in Tempus AI by 35.9% in the first quarter. ARK Investment Management LLC now owns 7,501,399 shares of the company’s stock worth $361,867,000 after purchasing an additional 1,981,755 shares in the last quarter. Voloridge Investment Management LLC boosted its holdings in Tempus AI by 183.0% in the third quarter. Voloridge Investment Management LLC now owns 1,607,083 shares of the company’s stock worth $129,708,000 after purchasing an additional 1,039,176 shares in the last quarter. Nikko Asset Management Americas Inc. increased its position in Tempus AI by 31.5% during the first quarter. Nikko Asset Management Americas Inc. now owns 4,260,553 shares of the company’s stock worth $205,401,000 after buying an additional 1,021,460 shares during the last quarter. Finally, BNP Paribas Financial Markets raised its holdings in Tempus AI by 312.7% during the third quarter. BNP Paribas Financial Markets now owns 1,274,549 shares of the company’s stock valued at $102,869,000 after buying an additional 965,730 shares in the last quarter. 24.22% of the stock is currently owned by institutional investors and hedge funds.

Analyst Ratings Changes

Several research firms have weighed in on TEM. TD Cowen cut shares of Tempus AI from a “buy” rating to a “hold” rating and set a $88.00 price objective on the stock. in a research report on Tuesday, October 21st. Morgan Stanley lifted their price target on Tempus AI from $68.00 to $80.00 and gave the company an “overweight” rating in a report on Tuesday, November 11th. Needham & Company LLC upped their price target on Tempus AI from $70.00 to $100.00 and gave the company a “buy” rating in a research report on Wednesday, November 5th. BTIG Research restated a “buy” rating and set a $96.00 price objective on shares of Tempus AI in a research report on Wednesday, November 5th. Finally, Weiss Ratings reaffirmed a “sell (d-)” rating on shares of Tempus AI in a research note on Wednesday, October 8th. Seven equities research analysts have rated the stock with a Buy rating, seven have issued a Hold rating and one has given a Sell rating to the stock. According to MarketBeat.com, Tempus AI presently has a consensus rating of “Hold” and a consensus price target of $80.00.

Tempus AI Company Profile

Tempus AI Inc is a technology company advancing precision medicine through the practical application of artificial intelligence principally in healthcare. The company provides AI-enabled precision medicine solutions to physicians to deliver personalized patient care and in parallel facilitates discovery, development and delivery of optimal therapeutics.